This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Informatics/ Internet in Medicine  • Internet  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;302(1):22.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A major expansion of public access to data from clinical trials is under way, as portions of a 2007 law are phased in.

The Food and Drug Administration Amendments Act required all nonpilot clinical trials of drugs, biologics, or devices regulated by the US Food and Drug Administration (FDA) to be registered at clinicaltrials.gov. Also, starting in September 2008, basic results from trials involving FDA-approved products were to be posted on the Web site.

Deborah A. Zarin, MD, director of clinicaltrials.gov, recently spoke with JAMA about the expansion of the database.

JAMA: Which data must be included in the basic results?

Dr Zarin: The basic results include participant flow, a table of key demographic information about the patients, and tables for each prespecified primary and secondary outcome. For each outcome measure, [the researchers] must post the summary results and may include statistical analyses.

We ask . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?